Healthcare

Modular Medical Enters Agreements With All Three Largest PBMs for Pivot Pump

Modular Medical said it has agreements with all three of the nation’s largest pharmacy benefit managers for its Pivot tubeless patch pump, while individual coverage remains subject to plan rules.

Published:
Reading Time
2 min

Modular Medical, Inc. (NASDAQ:MODD) said on November 19, 2026, that it has entered into agreements with the remaining two of the nation’s three largest pharmacy benefit managers (PBMs) for its Pivot tubeless patch pump. The company said the arrangements extend previously announced coverage across commercial, Medicare and Medicaid plans.

#Agreements Reach Three Largest PBMs

With the latest agreements, Modular Medical said all three of the largest PBMs now have arrangements covering Pivot. Their networks collectively cover more than 182 million lives and process approximately 80% of U.S. prescription claims, according to the company’s announcement.

The arrangements do not mean that every patient will receive coverage. Modular Medical said eligibility for an individual remains dependent on the formulary decision and benefit design of the relevant health plan or plan sponsor.

Jeb Besser, Modular Medical’s chief executive officer, said the agreements provide a basis for wider access to Pivot through standard pharmacy benefits and support the company’s commercial rollout over the coming year.

Mark Brady, the company’s director of managed markets, said access is an important factor in the adoption of insulin pump therapy. He linked the agreements to Modular Medical’s stated aim of making Pivot accessible and affordable for people who currently manage diabetes with multiple daily injections.

#About Pivot and Modular Medical

Modular Medical describes itself as a commercial-stage medical device company developing insulin delivery technologies intended to simplify diabetes management and increase access to pump therapy.

Pivot is a tubeless patch pump designed for people requiring intensive insulin therapy. The company says the product was developed to address barriers that have limited wider use of insulin pumps among patients using multiple daily injections.

#Terms and Risks Identified by the Company

Modular Medical said the potential benefits of the PBM agreements depend on whether health plans and plan sponsors adopt formulary coverage for Pivot. The company also identified the agreements’ terms, duration and potential termination, as well as reimbursement levels and pricing pressure, as factors that could affect their outcome.

Other risks listed by the company include the timing and success of Pivot’s commercial launch, market acceptance of its products and services, anticipated consumer demand, its ability to manufacture at high volumes and its ability to obtain sufficient capital to fund operations and commercialisation.

#Key Takeaways

  • Modular Medical said it has agreements with all three of the nation’s largest PBMs for Pivot.
  • The PBM networks collectively cover more than 182 million lives and process approximately 80% of U.S. prescription claims.
  • The arrangements apply across commercial, Medicare and Medicaid plans, subject to each health plan’s formulary and benefit design.
  • The company said the agreements support its commercial rollout of Pivot over the coming year.
  • Modular Medical identified formulary decisions, agreement terms, reimbursement levels, pricing pressure and commercial execution as relevant risks.

Original source: Read original article

Frequently Asked Questions